Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Information Letter on Actilyse® powder and solvent for solution for injection and infusion (alteplase) for acute ischaemic stroke: important extension of indication to include adolescents under 16 years of age
2018.06.22
Active substance: alteplase
Actilyse® has been licensed for treatment of acute ischaemic stroke in adolescent patients under 16 years of age.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN